To date, management of diabetes has focussed on enhanced insulin secretion or sensitivity to the hormone. An emerging strategy enhances renal elimination of glucose from the body by blocking the SGLT2 transporter. This spotlight of UEndcorine's Ask the Expert addresses questions related the SGLT2 inhibitors, an emerging treatment option.
Dr. Jordan Weinstein
Nephrologist, St. Michael's Hospital
Assistant Professor of Medicine, University of Toronto
Moderated by Dr. Alice Cheng, Chair, 2013 Clinical Practice Guidelines Committee, Canadian Diabetes Association
Dr. Alice Cheng has been involved as a professional volunteer with the Canadian Diabetes Association for several years. She works as an endocrinologist both at St. Michael’s Hospital and Credit Valley Hospital. She’s been with St. Michael’s since 2003 and Credit Valley since 2005.